{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:30:03Z","timestamp":1783344603272,"version":"3.54.6"},"reference-count":51,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>Background\/Objectives: This study aimed to investigate the prognostic value of advanced techniques of magnetic resonance imaging (MRI) biochemical recurrence (BCR) after radiotherapy in patients with prostate cancer (PCa). Methods: A comprehensive literature review was conducted to evaluate the role of MRI in detecting BCR of PCa patients after external beam radiation therapy. Results: National guidelines do not recommend imaging techniques in clinical follow-up PCa. However, in 2021, the European Association of Urogenital Radiology (ESUR), the European Association of Urological Imaging (ESUI), and the PI-RADS Steering Committee introduced the Prostate Imaging for Recurrence Reporting (PI-RR) system. PI-RR incorporates the MRI biomarkers in the post-treatment process. In the last decade, a growing number of clinical researchers have investigated the role of various MRI techniques in BCR. Conclusions: The integration of advanced MRI technologies into clinical routine marks the beginning of a new era of BCR with accuracy.<\/jats:p>","DOI":"10.3390\/clinpract15010004","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T02:59:27Z","timestamp":1735268367000},"page":"4","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Magnetic Resonance Imaging Techniques for Post-Treatment Evaluation After External Beam Radiation Therapy of Prostate Cancer: Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1290-1802","authenticated-orcid":false,"given":"Eleni","family":"Bekou","sequence":"first","affiliation":[{"name":"Medical Physics Laboratory, School of Medicine, Democritus University of Thrace, 69100 Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Admir","family":"Mulita","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy\/Oncology, School of Medicine, Democritus University of Thrace, 69100 Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3665-5271","authenticated-orcid":false,"given":"Ioannis","family":"Seimenis","sequence":"additional","affiliation":[{"name":"Medical Physics, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0575-8243","authenticated-orcid":false,"given":"Athanasia","family":"Kotini","sequence":"additional","affiliation":[{"name":"Medical Physics Laboratory, School of Medicine, Democritus University of Thrace, 69100 Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Courcoutsakis","sequence":"additional","affiliation":[{"name":"Radiology Department, School of Medicine, Democritus University of Thrace, 69100 Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2324-699X","authenticated-orcid":false,"given":"Michael I.","family":"Koukourakis","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy\/Oncology, School of Medicine, Democritus University of Thrace, 69100 Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7198-2628","authenticated-orcid":false,"given":"Francesk","family":"Mulita","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Karavasilis","sequence":"additional","affiliation":[{"name":"Medical Physics Laboratory, School of Medicine, Democritus University of Thrace, 69100 Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"ref_1","unstructured":"(2024, April 10). Cancer Today. Available online: https:\/\/gco.iarc.who.int\/today\/."},{"key":"ref_2","unstructured":"(2024, April 10). EAU Guidelines on Prostate Cancer\u2014Epidemiology and Aetiology\u2014Uroweb. Uroweb\u2014European Association of Urology. Available online: https:\/\/uroweb.org\/guidelines\/prostate-cancer\/chapter\/epidemiology-and-aetiology."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ctrv.2009.06.006","article-title":"Management of prostate cancer recurrence after definitive radiation therapy","volume":"36","author":"Boukaram","year":"2010","journal-title":"Cancer Treat. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_5","first-page":"1035","article-title":"Consensus statement: Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel","volume":"37","author":"Cox","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_6","unstructured":"(2024, April 12). PSA Test\u2014Mayo Clinic. Available online: https:\/\/www.mayoclinic.org\/tests-procedures\/psa-test\/about\/pac-20384731."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00345-014-1475-2","article-title":"Follow-up modalities in focal therapy for prostate cancer: Results from a Delphi consensus project","volume":"33","author":"Muller","year":"2015","journal-title":"World J. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10334-022-01006-6","article-title":"The Role of MRI in Prostate Cancer, Current and Future Directions","volume":"35","author":"Fernandes","year":"2022","journal-title":"MAGMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ucl.2018.03.011","article-title":"Prostate MR Imaging for Posttreatment Evaluation and Recurrence","volume":"45","author":"Gaur","year":"2018","journal-title":"Urol. Clin. N. Am."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"17.e1","DOI":"10.1016\/j.urolonc.2014.09.013","article-title":"Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: A randomized study","volume":"33","author":"Panebianco","year":"2015","journal-title":"Urol. Oncol."},{"key":"ref_11","unstructured":"(2024, March 28). PI-RADS|American College of Radiology. Available online: https:\/\/www.acr.org\/Clinical-Resources\/Reporting-and-Data-Systems\/PI-RADS."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jmri.26271","article-title":"Emerging role of MRI in radiation therapy","volume":"48","author":"Chandarana","year":"2018","journal-title":"Magn. Reson. Imaging"},{"key":"ref_13","unstructured":"(2024, April 11). Overview|Prostate Cancer: Diagnosis and Management|Guidance|NICE. Available online: https:\/\/www.nice.org.uk\/guidance\/ng131."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.euo.2021.01.003","article-title":"Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus-based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy","volume":"4","author":"Panebianco","year":"2021","journal-title":"Eur. Urol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2214\/AJR.22.28665","article-title":"PI-RR: The Prostate Imaging for Recurrence Reporting System for MRI Assessment of Local Prostate Cancer Recurrence After Radiation Therapy or Radical Prostatectomy\u2014A Review","volume":"220","author":"Dias","year":"2023","journal-title":"Am. J. Roentgenol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1148\/radiol.212252","article-title":"Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence Reporting Assessment Score","volume":"304","author":"Pecoraro","year":"2022","journal-title":"Radiology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00330-022-09095-6","article-title":"Magnetic resonance imaging for prostate cancer recurrence: It\u2019s time for precision diagnostic with Prostate Imaging for Recurrence Reporting (PI-RR) score","volume":"33","author":"Panebianco","year":"2023","journal-title":"Eur. Radiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bergaglio, C., Giasotto, V., Marcenaro, M., Barra, S., Turazzi, M., Bauckneht, M., Casaleggio, A., Sciab\u00e0, F., Terrone, C., and Mantica, G. (2023). The Role of mpMRI in the Assessment of Prostate Cancer Recurrence Using the PI-RR System: Diagnostic Accuracy and Interobserver Agreement in Readers with Different Expertise. Diagnostics, 13.","DOI":"10.3390\/diagnostics13030387"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1007\/s00330-023-09949-7","article-title":"An MRI assessment of prostate cancer local recurrence using the PI-RR system: Diagnostic accuracy, inter-observer reliability among readers with variable experience, and correlation with PSA values","volume":"34","author":"Franco","year":"2024","journal-title":"Eur. Radiol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ding, H., Velasco, C., Ye, H., Lindner, T., Grech-Sollars, M., O\u2019Callaghan, J., Hiley, C., Chouhan, M.D., Niendorf, T., and Koh, D.-M. (2021). Current Applications and Future Development of Magnetic Resonance Fingerprinting in Diagnosis, Characterization, and Response Monitoring in Cancer. Cancers, 13.","DOI":"10.3390\/cancers13194742"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1590\/S1677-55382009000200007","article-title":"T2-weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy","volume":"35","author":"Westphalen","year":"2009","journal-title":"Int. Braz. J. Urol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Koopman, A.G.M.M., Jenniskens, S.F.M., and F\u00fctterer, J.J. (2020). Magnetic Resonance Imaging Assessment After Therapy in Prostate Cancer. Top. Magn. Reson. Imaging, 29.","DOI":"10.1097\/RMR.0000000000000231"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3348\/kjr.2018.19.6.1110","article-title":"Functional Magnetic Resonance Imaging in the Diagnosis of Locally Recurrent Prostate Cancer: Are All Pulse Sequences Helpful?","volume":"19","author":"Liao","year":"2018","journal-title":"Korean J. Radiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.ijrobp.2021.03.039","article-title":"Oxygen-Sensitive MRI: A Predictive Imaging Biomarker for Tumor Radiation Response?","volume":"110","author":"Arai","year":"2021","journal-title":"Int. J. Radiat. Oncol. *Biol. *Phys."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.21037\/qims-21-331","article-title":"Three-dimensional nuclear magnetic resonance spectroscopy: A complementary tool to multiparametric magnetic resonance imaging in the identification of aggressive prostate cancer at 3.0t","volume":"11","author":"Deal","year":"2021","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2016.06.003","article-title":"Developing Oxygen-Enhanced Magnetic Resonance Imaging as a Prognostic Biomarker of Radiation Response","volume":"380","author":"White","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Wang, C., Padgett, K.R., Su, M.-Y., Mellon, E.A., Maziero, D., and Chang, Z. (2022). Multi-parametric MRI (mpMRI) for treatment response assessment of radiation therapy. Med. Phys., 49.","DOI":"10.1002\/mp.15130"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Belfatto, A., White, D.A., Zhang, Z., Zhang, Z., Cerveri, P., Baroni, G., and Mason, R.P. (2015, January 25\u201329). Mathematical modeling of tumor response to radiation: Radio-sensitivity correlation with BOLD, TOLD, \u0394R1 and \u0394R2* investigated in large Dunning R3327-AT1 rat prostate tumors. Proceedings of the 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Milan, Italy.","DOI":"10.1109\/EMBC.2015.7319089"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Asuncion, A., Walker, P.M., Bertaut, A., Blanc, J., Labarre, M., Martin, E., Bardet, F., Cassin, J., Cormier, L., and Crehange, G. (2022). Prediction of prostate cancer recurrence after radiation therapy using multiparametric magnetic resonance imaging and spectroscopy: Assessment of prognostic factors on pretreatment imaging. Quant. Imaging Med. Surg., 12.","DOI":"10.21037\/qims-22-184"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"W361","DOI":"10.2214\/AJR.12.9106","article-title":"Comparative Sensitivities of Functional MRI Sequences in Detection of Local Recurrence of Prostate Carcinoma After Radical Prostatectomy or External-Beam Radiotherapy","volume":"200","author":"Roy","year":"2013","journal-title":"Am. J. Roentgenol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/mrm.24846","article-title":"Correlations of noninvasive BOLD and TOLD MRI with pO2 and relevance to tumor radiation response","volume":"71","author":"Hallac","year":"2014","journal-title":"Magn. Reason. Med"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuroimage.2017.12.062","article-title":"What can we see with IVIM MRI?","volume":"187","year":"2019","journal-title":"NeuroImage"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mri.2024.02.008","article-title":"Intravoxel incoherent motion magnetic resonance imaging to assess early tumor response to radiation therapy: Review and future directions","volume":"108","author":"Mesny","year":"2024","journal-title":"Magn. Reason. Imaging"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kooreman, E.S., van Houdt, P.J., Keesman, R., van Pelt, V.W.J., Nowee, M.E., Pos, F., Sikorska, K., Wetscherek, A., M\u00fcller, A.-C., and Thorwarth, D. (2021). Daily Intravoxel Incoherent Motion (IVIM) In Prostate Cancer Patients During MR-Guided Radiotherapy-A Multicenter Study. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.705964"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kooreman, E.S., van Pelt, V., Nowee, M.E., Pos, F., van der Heide, U.A., and van Houdt, P.J. (2022). Longitudinal Correlations Between Intravoxel Incoherent Motion (IVIM) and Dynamic Contrast-Enhanced (DCE) MRI During Radiotherapy in Prostate Cancer Patients. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.897130"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s00066-020-01679-9","article-title":"The role of radiomics in prostate cancer radiotherapy","volume":"196","author":"Delgadillo","year":"2020","journal-title":"Strahlenther. Onkol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jmri.25335","article-title":"Haralick textural features on T2 -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer","volume":"45","author":"Gnep","year":"2017","journal-title":"J. Magn. Reason. Imaging"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/jmri.26178","article-title":"Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings","volume":"48","author":"Shiradkar","year":"2018","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11547-018-0966-4","article-title":"Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer","volume":"124","author":"Abdollahi","year":"2019","journal-title":"Radiol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11307-010-0342-9","article-title":"Protein-based MRI contrast agents for molecular imaging of prostate cancer","volume":"13","author":"Wei","year":"2011","journal-title":"Mol. Imaging Biol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Blasiak, B., MacDonald, D., Jasi\u0144ski, K., Cheng, F.-Y., and Tomanek, B. (2024). Application of H2N-Fe3O4 Nanoparticles for Prostate Cancer Magnetic Resonance Imaging in an Animal Model. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910334"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Grancharova, T., Zagorchev, P., and Pilicheva, B. (2024). Iron Oxide Nanoparticles: Parameters for Optimized Photoconversion Efficiency in Synergistic Cancer Treatment. J. Funct. Biomater., 15.","DOI":"10.3390\/jfb15080207"},{"key":"ref_43","unstructured":"Hussain, C.M., and Patankar, K.K. (2022). Magnetic nanoparticles as contrast agents in magnetic resonance imaging and radiosensitizers in radiotherapy. Fundamentals and Industrial Applications of Magnetic Nanoparticles, Woodhead Publishing."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5152\/dir.2018.17285","article-title":"Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy","volume":"24","author":"Valle","year":"2018","journal-title":"Diagn. Interv. Radiol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Faiella, E., Santucci, D., D\u2019Amone, G., Cirimele, V., Vertulli, D., Bruno, A., Beomonte Zobel, B., and Grasso, R.F. (2024). Focal Minimally Invasive Treatment in Localized Prostate Cancer: Comprehensive Review of Different Possible Strategies. Cancers, 16.","DOI":"10.3390\/cancers16040765"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00259-016-3594-z","article-title":"Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET\/CT and PET\/MRI: Comparison with mpMRI integrated in simultaneous PET\/MRI","volume":"44","author":"Freitag","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Glemser, P.A., Rotkopf, L.T., Ziener, C.H., Beuthien-Baumann, B., Weru, V., Kopp-Schneider, A., Schlemmer, H.P., Dimitrakopoulou-Strauss, A., and Sachpekidis, C. (2022). Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer. Cancer Imaging, 22.","DOI":"10.1186\/s40644-022-00489-9"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Cattabriga, A., Renzetti, B., Galuppi, F., Bartalena, L., Gaudiano, C., Brocchi, S., Rossi, A., Schiavina, R., Bianchi, L., and Brunocilla, E. (2024). Multiparametric Whole-Body MRI: A Game Changer in Metastatic Prostate Cancer. Cancers, 16.","DOI":"10.3390\/cancers16142531"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00330-021-08140-0","article-title":"Prospective comparison of simultaneous [68Ga]Ga-PSMA-11 PET\/MR versus PET\/CT in patients with biochemically recurrent prostate cancer","volume":"32","author":"Jentjens","year":"2022","journal-title":"Eur. Radiol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Shaikh, F., Dupont-Roettger, D., Dehmeshki, J., Kubassova, O., and Quraishi, M.I. (2020). Advanced Imaging of Biochemical Recurrent Prostate Cancer With PET, MRI, and Radiomics. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01359"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2967\/jnumed.123.266527","article-title":"Diagnostic Performance of 68Ga-PSMA-11 PET\/CT Versus Multiparametric MRI for Detection of Intraprostatic Radiorecurrent Prostate Cancer","volume":"65","author":"Light","year":"2024","journal-title":"J. Nucl. Med."}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-7283\/15\/1\/4\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:01:04Z","timestamp":1760115664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/15\/1\/4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["clinpract15010004"],"URL":"https:\/\/doi.org\/10.3390\/clinpract15010004","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]}}}